Clinical trial
Meta-analysis in Post-Marketing Surveillances for Long-Term Drug Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
NCT02284269 is registered in ClinicalTrials.gov with Pharmaceuticals and Medical Devices Agency, Japan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Meta-analysis in Post-Marketing Surveillances for Long-Term Drug Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- Pharmaceuticals and Medical Devices Agency, Japan
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2014
- Completion date
- Not reported
- Enrollment
- 18,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.